Hong Kong Biotech Breakthroughs

Akeso

Market Cap: HK$74.6b

A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.

Beijing Luzhu Biotechnology

Market Cap: HK$4.1b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$70.9b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Everest Medicines

Market Cap: HK$13.9b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

CanSino Biologics

Market Cap: HK$11.6b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

TYK Medicines

Market Cap: HK$8.1b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

Cutia Therapeutics

Market Cap: HK$2.8b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Innovent Biologics

Market Cap: HK$96.7b

A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.

CStone Pharmaceuticals

Market Cap: HK$4.8b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in China and internationally.